Marijuana Research Today is a free monthly online journal that collates and summarizes the latest research about Marijuana, including details on benefits, cancer, effects, uses, addiction.

Volume 4 (2007), Issue 5 (May)

1. Comparison of indirect assessments of association as predictors of marijuana use among at-risk adolescents.
   Exp Clin Psychopharmacol, 15(2): 204-18. [Abstract] [Full-text]
2. Heterozygous neuregulin 1 mice are more sensitive to the behavioural effects of Delta9-tetrahydrocannabinol.
   Psychopharmacology (Berl), 192(3): 325-36. [Abstract] [Full-text]
3. The CRF1 receptor antagonist R121919 attenuates the neuroendocrine and behavioral effects of precipitated lorazepam withdrawal.
   Psychopharmacology (Berl), 192(3): 385-96. [Abstract] [Full-text]
4. Substance-use outcomes at 18 months past baseline: the PROSPER Community-University Partnership Trial.
   Am J Prev Med, 32(5): 395-402. [Abstract] [Full-text]
5. A biosocial-affect model of adolescent sensation seeking: the role of affect evaluation and peer-group influence in adolescent drug use.
   Prev Sci, 8(2): 89-101. [Abstract] [Full-text]
6. A stepped care approach for reducing cannabis use in opioid-dependent outpatients.
   J Subst Abuse Treat, 32(4): 341-7. [Abstract] [Full-text]
7. Adolescent salvia substance abuse.
   Addiction, 102(5): 823-4. [Abstract] [Full-text]
8. The role of substance use in young adult divorce.
   Addiction, 102(5): 786-94. [Abstract] [Full-text]
9. The tumour suppressor protein, p53, is involved in the activation of the apoptotic cascade by Delta9-tetrahydrocannabinol in cultured cortical neurons.
   Eur J Pharmacol, 564(1): 57-65. [Abstract] [Full-text]
10. Acute effects of smoked marijuana on decision making, as assessed by a modified gambling task, in experienced marijuana users.
    J Clin Exp Neuropsychol, 29(4): 357-64. [Abstract] [Full-text]
11. Medical marijuana and the developing role of the pharmacist.
    Am J Health Syst Pharm, 64(10): 1037-44. [Abstract] [Full-text]
12. Deterioration of academic achievement and marijuana use onset among rural adolescents.
    Health Educ Res, 22(3): 372-84. [Abstract] [Full-text]
13. Marijuana use among young women in a primary care setting.
    J Gen Intern Med, 22(6): 826-9. [Abstract] [Full-text]
14. Nicotinic facilitation of delta9-tetrahydrocannabinol discrimination involves endogenous anandamide.
    J Pharmacol Exp Ther, 321(3): 1127-34. [Abstract] [Full-text]
15. Correlates of suicidal ideation among HIV-positive persons.
    AIDS, 21(9): 1199-203. [Abstract] [Full-text]
16. The protective effects of ethnic identity for alcohol and marijuana use among Black young adults.
    Cultur Divers Ethnic Minor Psychol, 13(2): 187-93. [Abstract] [Full-text]
17. Opioid antagonism of cannabinoid effects: differences between marijuana smokers and nonmarijuana smokers.
    Neuropsychopharmacology, 32(6): 1391-403. [Abstract] [Full-text]
18. Maternal partner criminality and cannabis use in young adulthood: prospective study.
    Aust N Z J Psychiatry, 41(6): 546-53. [Abstract] [Full-text]
19. Dorsolateral prefrontal cortex N-acetylaspartate/total creatine (NAA/tCr) loss in male recreational cannabis users.
    Biol Psychiatry, 61(11): 1281-9. [Abstract] [Full-text]
20. Effect of cannabinoids on platelet serotonin uptake.
    Addict Biol, 12(2): 158-66. [Abstract] [Full-text]
21. The effects of price and perceived quality on the behavioural economics of alcohol, amphetamine, cannabis, cocaine, and ecstasy purchases.
    Drug Alcohol Depend, 89(2): 107-15. [Abstract] [Full-text]
22. Nicotinic alpha 7 receptors as a new target for treatment of cannabis abuse.
    J Neurosci, 27(21): 5615-20. [Abstract] [Full-text]
23. Cannabidiol, unlike synthetic cannabinoids, triggers activation of RBL-2H3 mast cells.
    J Leukoc Biol, 81(6): 1512-22. [Abstract] [Full-text]
24. The Marijuana Check-up: promoting change in ambivalent marijuana users.
    Addiction, 102(6): 947-57. [Abstract] [Full-text]
25. Combined immunomodulating properties of 3,4-methylenedioxymethamphetamine (MDMA) and cannabis in humans.
    Addiction, 102(6): 931-6. [Abstract] [Full-text]
26. Factor and item-response analysis DSM-IV criteria for abuse of and dependence on cannabis, cocaine, hallucinogens, sedatives, stimulants and opioids.
    Addiction, 102(6): 920-30. [Abstract] [Full-text]
27. Motives for cannabis use as a moderator variable of distress among young adults.
    Addict Behav, 32(8): 1537-45. [Abstract] [Full-text]
28. The urinary disposition of intravenously administered 11-nor-9-carboxy-delta-9-tetrahydrocannabinol in humans.
    Ther Drug Monit, 29(3): 368-72. [Abstract] [Full-text]
29. Concurrent alcohol and tobacco use during early adolescence characterizes a group at risk.
    Alcohol Alcohol, 42(3): 219-25. [Abstract] [Full-text]
30. Factors associated with the use of solvents and cannabis by medical students.
    Addict Behav, 32(8): 1740-4. [Abstract] [Full-text]
31. "It wasn't me, it was them!" social influence in risky behavior by adolescents.
    J Health Econ, 26(4): 763-84. [Abstract] [Full-text]
32. Depressive symptoms in adolescents: associations with white matter volume and marijuana use.
    J Child Psychol Psychiatry, 48(6): 592-600. [Abstract] [Full-text]
33. Cannabis induces different cognitive changes in schizophrenic patients and in healthy controls.
    Prog Neuropsychopharmacol Biol Psychiatry, 31(5): 1054-63. [Abstract] [Full-text]
34. Chronic cannabis use does not affect the normalization of hypothalamic-pituitary-adrenal (HPA) axis induced by methadone in heroin addicts.
    Prog Neuropsychopharmacol Biol Psychiatry, 31(5): 1089-94. [Abstract] [Full-text]

© 2004-2008 Marijuana Research Today. All Rights Reserved.